1. Home
  2. PROF vs SERA Comparison

PROF vs SERA Comparison

Compare PROF & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • SERA
  • Stock Information
  • Founded
  • PROF N/A
  • SERA 2008
  • Country
  • PROF Canada
  • SERA United States
  • Employees
  • PROF N/A
  • SERA N/A
  • Industry
  • PROF Medical/Dental Instruments
  • SERA Precision Instruments
  • Sector
  • PROF Health Care
  • SERA Health Care
  • Exchange
  • PROF Nasdaq
  • SERA Nasdaq
  • Market Cap
  • PROF 238.5M
  • SERA 258.3M
  • IPO Year
  • PROF N/A
  • SERA 2021
  • Fundamental
  • Price
  • PROF $7.66
  • SERA $6.93
  • Analyst Decision
  • PROF Strong Buy
  • SERA
  • Analyst Count
  • PROF 2
  • SERA 0
  • Target Price
  • PROF $11.40
  • SERA N/A
  • AVG Volume (30 Days)
  • PROF 74.1K
  • SERA 140.4K
  • Earning Date
  • PROF 10-31-2024
  • SERA 11-06-2024
  • Dividend Yield
  • PROF N/A
  • SERA N/A
  • EPS Growth
  • PROF N/A
  • SERA N/A
  • EPS
  • PROF N/A
  • SERA N/A
  • Revenue
  • PROF $7,880,000.00
  • SERA $107,000.00
  • Revenue This Year
  • PROF $56.87
  • SERA N/A
  • Revenue Next Year
  • PROF $161.94
  • SERA $2,020.00
  • P/E Ratio
  • PROF N/A
  • SERA N/A
  • Revenue Growth
  • PROF 16.67
  • SERA N/A
  • 52 Week Low
  • PROF $7.11
  • SERA $1.56
  • 52 Week High
  • PROF $11.69
  • SERA $12.36
  • Technical
  • Relative Strength Index (RSI)
  • PROF 44.89
  • SERA 42.10
  • Support Level
  • PROF $7.55
  • SERA $6.87
  • Resistance Level
  • PROF $8.48
  • SERA $7.27
  • Average True Range (ATR)
  • PROF 0.30
  • SERA 0.48
  • MACD
  • PROF 0.06
  • SERA -0.09
  • Stochastic Oscillator
  • PROF 39.34
  • SERA 2.21

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

Share on Social Networks: